Development and external validation of a nomogram for predicting overall survival of patients with non-endometrioid endometrial cancer: A population-based analysis
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Reference20 articles.
1. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial;de Boer;Lancet Oncol.,2018
2. Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: a systematic review and meta-analysis;Yi;Gynecol. Oncol.,2018
3. Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer;Goodman;Gynecol. Oncol.,2019
4. Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: outcomes by risk factors;Tatebe;Gynecol. Oncol.,2019
5. Predictors of survival in women with high-risk endometrial cancer and comparisons of sandwich versus concurrent adjuvant chemotherapy and radiotherapy;Chen;Int. J. Environ. Res. Publ. Health,2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3